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Abstract
Transcription factors LXRs, PPARs, and SREBPs have been implicated in a multitude of physiological and pathological
processes including atherogenesis. However, little is known about the regulation of these transcription factors at different
stages of atherosclerosis progression. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to compare the
contents of mRNAs in pairs intact-injured aorta fragments taken from the same donors. Only minor changes in LXRa, LXRb,
PPARa, PPARc, SREBP1, and SREBP2 mRNA levels were found in initial lesions as compared with intact non-diseased tissue.
The contents of all mRNAs but SREBP2 mRNA were found to be progressively up-regulated in fatty streaks and fibrous lipoid
plaques. These changes were only partially reproduced in cultured macrophages upon lipid loading. Wave-shaped changes
in abundance of correlations between given group of mRNAs and 28 atherosclerosis-related mRNA species in the course of
atherogenesis were observed. The impact of specific mRNA correlations on the total correlations also significantly varied
between different lesion types. The study suggests that the extent and forms of LXR/PPAR/SREBP participation in intima
functions vary nonlinear in individual fashion in atherogenesis. We speculate that the observed changes in mRNAs
expression and coupling reflect shifts in lipid ligands availability and cellular composition in the course of atherosclerosis
progression.
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Introduction
Local inflammation and lipid accumulation are two hallmarks
of atherosclerosis. These processes are mutually dependent, so that
the final outcome, i.e. plaque formation, is the same for both lipid
and inflammatory stimuli (reviewed in [1]). The balance between
lipids entrance into vessel wall, their local biosynthesis and
degradation, as well as reverse transfer is maintained mainly by
oxysterol sensors LXRa,b (liver X receptors alpha, beta), fatty
acids sensors PPARa,b/d,c (peroxisome proliferator-activated
receptors alpha, beta/delta, and gamma), and SREBP1,2 (sterol
response element-binding proteins 1, 2) whose activity is inhibited
by cholesterol at the level of post-translational processing
(reviewed in [2–7]). All these proteins are transcription factors
that interact with response elements found in a multitude of genes
engaged in lipid turnover including their own genes. Moreover,
LXRs and PPARs were found to participate in negative regulation
of pro-inflammatory genes while, in turn, being the objects of
inflammatory stimuli (reviewed in [8,9]). It is not fully understood
why the system of lipid homeostasis fails to prevent foam cell
formation and following plaque development. As an explanation,
inefficient targeting of modified lipoproteins for degradation was
proposed, although underlying mechanisms remain uncertain.
The comparison between healthy humans and patients with
familial hypercholesterolemia showed that normally, approximate-
ly 2/3 of low density lipoprotein (LDL) is eliminated from the
bloodstream via LDL receptor-mediated endocytosis (reviewed in
[10]). Many risk factors such as dyslipidemia, diabetes mellitus,
smoking, etc. provoke enzymatic and non-enzymatic formation of
modified LDLs (mLDLs) which enter the cell through various
scavenger receptors (such as SR-A and CD36) mediated endocy-
tosis, phagocytosis and by pinocytosis [11]. Within the cell,
cholesterol is distributed between lysosomal compartment and
lipid droplets as esters with fatty acids formed by acyl-CoA-
cholesterol acyltransferase (ACAT). Intracellular transfer is per-
formed using endosomes and autophagosomes. Along with
cholesterol import, a system of endogenous cholesterol biogenesis
exists. Unlike fatty acids, cholesterol cannot be completely
disrupted in the body. Its elimination occurs via bile, in forms of
free cholesterol, cholesteryl esters and bile acid derivatives
synthesized in the liver. From arterial wall, an excess of cholesterol
is removed by a system of reverse transfer that includes liver-
derived cholesterol acceptors, ATP-binding cassette transporters,
and accessory proteins, such as receptor for high density
lipoprotein (HDL), SR-BI, and apolipoprotein E (ApoE) which
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enhances the capacity of HDL. As a preliminary step, cholesterol
esters are hydrolyzed by cholesteryl ester hydrolase (CEH). The
function of this cleaning is usually attributed to macrophages, but
it is not obvious since, as shown here, all these components of
reverse transfer are expressed (at the level of transcription) in
resident cells of the aortic intima.
Our current knowledge about artery wall biology is based
primary on the studies utilizing macrophages which compose,
however, only minor cell population even in advanced athero-
sclerotic lesions. Moreover, several populations of macrophages
with different phenotypes can co-exist within the aorta [12]. Less is
known about more numerous resident cells of the vessel including
smooth muscle cells which were shown to contribute to foam cell
formation (reviewed in [13]). So, it is important to analyze control
mechanisms of lipid homeostasis in the majority of arterial cells
during the development and progression of atherosclerotic lesions.
Materials and Methods
This study was kept in accordance with the Helsinki Declaration
of 1975 as revised in 1983. It was approved by the local ethics
committees of the Russian Cardiology Research and Production
Complex, Moscow, and Institute for Atherosclerosis Research,
Skolkovo Innovation Center, Moscow, Russia. This study utilized
autopsy tissue specimens. Written informed consent for the use of
the tissue samples for our study was obtained from relatives of
subjects who died from accidental death in each case.
Artery Samples
This study used aorta samples extracted during autopsies from
13 men aged 31–55 years (median 49 years) and 6 women aged
39–57 years (median 48 years) 4–6 hours after accidental death.
The vessels were dissected longitudinally and washed with PBS.
Upon macroscopic examination, dissected fragments were divided
in half for biochemical and histological analyses. For mRNA
measurements, the intima from the apparently normal and the
atherosclerotically damaged areas (types I, II, and Va, i.e. initial
lesions, fatty streaks, and fibroatheroma or fibrolipid plaques) were
mechanically separated, frozen in liquid nitrogen, and kept at
270uC. No lesion shoulders were taken for analysis. The ascribing
of samples to certain morphological types of atherosclerotic
damages was confirmed microscopically according to American
Heart Association classification [14,15]. Comparisons between
intact and injured tissue were performed in pairs of intact/injured
fragments taken from the same donors. Such pairs included 17
fragments with type I lesions, 18 fragments with type II lesions,
and 11 fragments with type Va lesions.
Isolation of Monocyte-derived Macrophages
Mononuclear cells were isolated from the fasting venous blood
of 8 healthy volunteers (five men and three women) aged 21–57
years with their written informed consent. The isolation was
performed by centrifugation on a Ficoll-Paque Plus (Amersham
Biosciences; Uppsala, Sweden) density gradient according the
manufacturer’s protocol.
To prepare the monocyte-derived macrophages, mononuclear
cell suspensions in DMEM (GibcoBRL Life Technologies; Grand
Figure 1. Expression levels of mRNAs encoding for lipid sensors/transcriptional regulators in aortas from men (black bars), women
(hatched bars), and in combined M+F population (grey bars). Symbol # makes a note gender difference. A, intact aortas (men, n = 15,
women, n = 6); B, lesions of type I (men, n = 11, women, n = 6), C, lesions of type II (men, n = 13, women, n = 5), D, lesions of type Va (men, n = 9,
women, n = 2).
doi:10.1371/journal.pone.0063374.g001
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Island, NY, USA) containing 10% fetal bovine serum (ICN
Biochemicals Inc.; Costa Mesa, CA, USA), 2 mM glutamine,
100 mg/mL kanamycin and 2.5 mg/mL fungizone were plated
onto 35-mm plastic culture dishes (Corning Costar; Corning, NY,
USA) at a density of 36106 cells per dish. Cells were cultivated at
100% humidity and 37uC in a CO2 incubator (5% CO2 and 95%
atmosphere air) for 7–10 days with medium changes every other
day.
Macrophage Loading with Lipids
Lipid-loaded monocyte-derived macrophages were prepared
using freshly isolated naturally modified LDLs which were isolated
from the pooled serum of patients with diagnosed atherosclerosis
(with their written informed consent) by a two-stage ultracentri-
fugation in a discontinuous density gradient of sodium bromide.
The LDL fraction thus obtained was dialyzed against PBS for 12
hours at 4uC and sterilized by filtration using a pore size of
0.45 mm. A volume of 100 mg/mL of mLDL was added to the
cells and incubated for 18 hours. Control cells were incubated
without added LDLs. As an additional control, LDLs from pooled
serum of healthy blood donors were used instead of mLDLs. Cells
were then washed three times with PBS, lysed with trizol, and kept
at 270uC or used for cholesterol measurements.
To confirm mLDL-induced cholesterol accumulation in the
macrophages, cells were extracted three times with a hexan/
isopropanol mixture (3:2, v/v). The cholesterol content was
determined enzymatically using a reagents kit from BioconH
Diagnostik (Marienhagen, Germany). The protein content was
measured with Folin reagent [16].The intracellular cholesterol
level was normalized to the protein content in each sample. As a
result, 2 to 3-fold increase in cholesterol content was observed
upon incubation of macrophages with mLDLs. No cholesterol
accumulation was found with native LDLs of healthy donors.
RNA Isolation and Real-time PCR
RNA was isolated by a homogenization of the frozen samples
taken from the vessel walls in TRIzol Reagent (Invitrogen;
Carlsbad, CA, USA). The RNA was then treated with
chloroform, precipitated with isopropanol, and washed with
ethanol. The synthesis of cDNA was performed on 2–6 mg of
total RNA using a Promega ImProm_IITM Reverse Transcrip-
tion System kit (Promega Corporation; Madison, WI, USA).
The synthesized cDNA was used as a template for quantitative
real-time polymerase chain reaction (qRT-PCR) on a Rotor-
Gene 3000 amplifier (Corbett Research; Sydney, Australia) with
a kit of reagents including the intercalating dye SYBR Green I
(Syntol; Moscow, Russia) as recommended by the manufacturer.
The details of amplification were described earlier [17]. The
primers for the most part of mRNAs were chosen using the
Beacon Designer 6.00 program (www.PremierBiosoft.com) and
described previously [18]. The primers for the second house-
keeping gene, guanine nucleotide-binding protein, beta-peptide
2-like 1 (GNB2L1) were the same as in report of Ishii et al [19].
To check for the absence of products amplified from genomic
DNA, isolated RNA was used as a template. Amplified products
were sequenced using an ABI PRISMH BigDyeTM Terminator
v.3.1 kit of reagents and an ABI PRISM 3100-Avant automated
DNA sequencer to confirm the expected sequences available in
relevant databases. No new DNA sequences were revealed in
this study. The results were included only when the melting
temperature and the electrophoretic mobility of the amplified
products corresponded to the expected values. DNA sequencing
was performed in the Center of Collective Use ‘‘Genome’’ at
the Engelhardt Institute of Molecular Biology. The content of
the particular mRNAs was normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA content as an
internal reference control and expressed as percent.
Immunohistochemistry
Tissue blocks of aortic wall segments were cross-cut into 6 mm
tissue sections. For immunostaining, after elimination of endog-
enous peroxidase activity by 3% H2O2, sections were preincubat-
ed with normal non-immune serum and then tested by avidin-
Figure 2. The ratios of the contents of mRNAs encoding for
lipid sensors/transcriptional regulators in pairs of injured/
intact aortas from men (black bars), women (hatched bars),
and in combined M+F population (grey bars). Symbol # shows
significant difference from 1.0. Symbol * makes a note gender
difference. A, lesion of type I/intact tissue ratios (men, n = 11, women,
n = 6); B, lesion of type II/intact tissue ratios (men, n = 13, women, n = 5);
C, lesion of type Va/intact tissue ratios (men, n = 9, women, n = 2).
doi:10.1371/journal.pone.0063374.g002
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biotin complex (ABC) using a standard ABC immunoperoxidase
method. LXRa, PPARc and SREBP1 were identified using
antibodies from Santa Cruz Biotechnology Inc. (LXRa Antibody
(P-20): sc-1202; dilution: 1:200; PPARc Antibody (B-5): sc-
271392; dilution: 1:200; SREBP-1 Antibody (C-20): sc-366;
dilution: 1:200; accordingly). After washing in tris-phosphate
buffered saline (TPBS), pH 7.6, the sections were incubated with
an appropriate biotin-labelled secondary antibody, followed by a
treatment with avidin-biotin complex (Elite ABC, Vector
PK61000). After washing in TPBS, brown staining was produced
by 5 min treatment with 3,39-diaminobenzidine (DAB). All the
incubations were completed at room temperature. For negative
controls, the first antibodies were omitted or the sections were
treated with an immunoglobulin fraction of non-immune serum as
a substitute for the primary antibody. None of the negative control
sections showed positive immune staining. Counterstaining was
performed with Mayer’s haematoxylin.
Statistical Analysis
The results were analyzed with the Statistica 7.0 program.
Independent samples were compared using the Mann-Whitney U-
test. Correlations were evaluated using the Spearman rank test.
Differences or correlations were considered significant at p,0.05.
Mean 6 SD values are shown. Correlation graph weight values
Gh were calculated as sum of modules of statistically significant
pairwise correlation coefficients (rkl): Gh =g |rkl| [20].
Figure 3. Increase in LXRa, PPARc, and SREBP1 (B, D, F, respectively) immunopositivity in atherosclerotic lesions (fibroatheroma)
compared with those (A, C, E, respectively) in non-atherosclerotic segments of the aorta. Immunohistochemistry; ABC
immunoperoxidase method. Bars = 100 mm (A–F).
doi:10.1371/journal.pone.0063374.g003
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Results
The Contents of mRNAs in Intact Aorta and Aorta
Fragments with Atherosclerotic Injures
To validate the relevancy of GAPDH mRNA as reference
point, we have analyzed the expression of the additional
housekeeping gene, GNB2L1, in intact and injured aorta
fragments from several donors. The ratios of GNB2L1 mRNA
contents in injures to its contents in intact aorta fragments, as
normalized by GAPDH mRNA, were close to 1.0 for lesions of
type I, II, and Va (0.9460.38 (n = 6), 0.9660.24 (n = 6), and
0.8860.11 (n = 4), respectively). The data suggests that the
expression of two housekeeping genes does not vary significantly
during atherogenesis.
Among the group of LXR/PPAR/SREBP mRNAs, the
contents of PPARc and SREBP1 mRNAs showed significant
gender differences with higher levels in intact male or female
aortas, respectively (Fig. 1A). Sex difference in the contents of
PPARc mRNA persisted also in lesions of type I (Fig. 1B). An
additional level of sex differentiation was found in lesions of type
II, where the ratio of lesion/intact aorta for SREBP2 mRNA
contents in women tissues was significantly below 1.0, while in
men this ratio had a tendency to rise (Fig. 2). In combined male
plus female population, no age correlations of LXR/PPAR/
SREBP mRNA contents were found in intact aorta (n = 21) and
lesions of types I (n = 17) and II (n = 18). However, in combined
(n = 11) and male (n = 9) populations, LXRa mRNA correlated
positively with age in lesions of type Va. Unexpectedly, only in
female population, positive age correlations were found for LXRa,
PPARc, SREBP1 and SREBP2 mRNAs in lesions of type II. The
later finding should be taken guardedly due to small population
size (n = 5).
As shown in Figures 2A-C, the content of all but one (SREBP2)
tested mRNAs encoding for lipid sensors/transcriptional regula-
tors progressively increased during atherosclerosis progression.
More prominent rise was observed for LXRa, PPARc, and
SREBP1 mRNAs as compared with LXRb and PPARa mRNAs.
The levels of SREBP2 mRNA were resistant to the disease. For
markers (LXRa, PPARc, and SREBP) which were found to
demonstrate the most prominent increases in mRNAs levels, we
further undertook immunohistochemical staining in order to see if
would be possible to visualize such increases. Indeed, immuno-
histochemistry unambiguously demonstrated increases in LXRa,
PPARc, and SREBP1 immunopositivity levels in atherosclerotic
lesions compared with non-atherosclerotic segments of the aorta
(Fig. 3A-F).
Correlations between mRNAs in Intact and Injured Aorta
Figure 4 demonstrates the presence of multiple correlations
between mRNAs encoding for lipid sensors/transcriptional
regulators and other mRNA species both in intact and injured
aorta. The abundance and pattern of these correlations were
individual for each tissue type, although a number of them were
conservative, i.e. found in at least two tissue types.
Correlations between mRNAs contents underwent to significant
quantitative and qualitative changes in the course of atherogenesis.
The cohesiveness of variables had a wavy shape with maximal
Figure 4. Correlations between the contents of mRNAs coding for lipid sensors/transcriptional regulators and mRNA species of
other functional groups in intact and injured human aortas. Significant Rs values for positive and negative correlations are shown in bold and
italics, respectively. * - Type I lesion -initial lesion; type II lesion - fatty streak; and type Va lesion – fibroatheroma [14,15]. ** - rkl values within LXR/
PPAR/SREBP group were halved, and each half was ascribed to the correspondent column (e.g. Rs of 0.60 for correlation LXRa-PPARa in lesion of type
I gives additional 0.30 to the column for LXRa while the same value of 0.30 was subtracted from the sum of PPARa column. Abbreviations: ABCG1,
ATP-binding cassette transporter G1; AR, androgen receptor; SELE, E-selectin; Arom, aromatase; EST, estrogen sulfotransferase; Lamp 1/2, lysosome-
associated membrane glycoproteins 1 and 2; LDLR, low density lipoprotein receptor; STS, steroid sulfatase; TNFa, tumor necrosis factor a; TfR1,
transferrin receptor 1; VCAM1, vascular cell adhesion molecule 1 (other abbreviations are given in the text earlier).
doi:10.1371/journal.pone.0063374.g004
Figure 5. Expression levels of mRNAs encoding for lipid sensors/transcriptional regulators in control macrophages frommen (n=5,
black bars) and women (n=3, hatched bars).
doi:10.1371/journal.pone.0063374.g005
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graph weight found in lesions of type II and minimum in lesions of
type I (Fig. 4).
The involvement of individual members of the group of mRNAs
encoding for lipid sensors/transcriptional regulators in correlations
were subjected to even more pronounced changes (Fig. 4). PPARc
mRNA was the main contributor to correlations in intact tissue. In
initial lesions, a significant rise in contribution of SREBP1 mRNA
was observed. In fatty streaks, the contribution of all six mRNA
species to correlations was equalized. In fibrolipid plaques,
SREBP1 and SREBP2 mRNAs lost near all their correlations.
The main features of this lesion type were enormous amounts of
negative correlations that involved LXRb and PPARa mRNAs.
An additional level of complexity in evolution of correlations arise
due to change in sign of correlations PPARc-EEA1 (early
endosome antigen 1), and PPARc-Rab5a (Ras-related small
GTPase 5A) at transition from intact tissue to lesion of type Va.
With the exception of PPARc mRNA, the contents of mRNAs
for lipid sensors/transcriptional regulators in early lesions (of types
I and II) correlated with their levels in intact tissue. However, in
advanced lesions (of type Va), LXRa and SREBP1 mRNAs lost
correlations with their contents in intact tissue (data not shown).
Expression of mRNAs in Macrophages
In control macrophages, expression levels of all mRNAs
encoding for lipid sensors/transcriptional regulators and particu-
larly LXRa (Fig. 5) exceeded those in intact aorta (cf. with Fig. 1).
No gender differences were observed.
The loading of macrophages with lipids from mLDL that to
some extent mimics foam cells formation in atheroma was
associated with significant changes in expression of 3 from 6
mRNA species: an increase in the contents of LXRb and PPARa
mRNAs and decrease in the level of SREBP2 mRNA (Fig. 6).
Thus, the changes in mRNAs expression in whole aorta intima
during atherosclerosis progression (Fig. 2) and in macrophages
after lipid loading have only partial similarity.
An analysis of correlations between the contents of different
mRNA species in control macrophages revealed in all 6
correlations, 2 of which coinciding with correlations in aorta
(Fig. 7). Lipid loading of macrophages was associated with 2.5-fold
rise in the number of correlations with significant increase in
shared for macrophages and aorta correlations. Interestingly,
correlation LXRb-CEH mRNA found in both control and lipid-
loaded macrophages was absent in any type of aorta tissue.
Discussion
First of all, correlations between mRNAs are considered herein
as a reflection of relationships between mRNA species in the
majority of cells that compose the analyzed tissue. Thus, the shifts
in both cellular composition and inner links between mRNAs can
be responsible for the observed changes in correlations during
pathogenesis. The interpretation of correlations is further compli-
cated by the necessity of taking into account the availability of
LXR and PPAR ligands that control activities of these transcrip-
tion factors.
According to the theory of correlation adaptometry [20,21],
unfavorable conditions induce more tight coupling between
analyzed parameters in different biological systems. For example,
the cohesiveness between biochemical parameters rises with
disorder severity and drops after successful treatment. From this
point of view, the most stressing conditions for intima cells exist in
fatty streaks, since both amount of correlations and correlation
graph weight are maximal in this lesion among aorta tissue types
studied (Fig. 4). Unexpectedly, initial lesions are characterized by
the lowest level of involvement of LXR/PPAR/SREBP mRNA
group in correlations. This discrepancy might be attributed to
interference of mRNA from macrophage-derived foam cells with
mRNA from resident intima cells. However, no one from several
correlations shared for intact intima and lipid-loaded macrophages
(PPARa-PPARc, PPARc-SR-A, PPARa- acyl-CoA-cholesterol
acyltransferase 1(ACAT1), PPARc-ACAT1, PPARc- Toll-like
receptor 4(TLR4)) was preserved in initial lesions. Accordingly,
some more fundamental factors responsible for lowering of LXR/
PPAR/SREBP group involvement in coupling of gene expression
in initial lesions can be suggested. Taking into account that initial
lesions are found even in infants, foam cells formation in these
Figure 6. The ratios of the contents of mRNAs encoding for lipid sensors/transcriptional regulators in lipid-loaded and control
macrophages (n=8). Symbol # shows significant difference from 1.0.
doi:10.1371/journal.pone.0063374.g006
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Figure 7. Correlations between the contents of mRNAs encoding for lipid sensors/transcriptional regulators and mRNA species of
other functional groups in control and lipid-loaded macrophages. Positive and negative correlations are shown in bold and italics,
respectively. Asterisks mark off correlations common for macrophages and intact and/or injured aorta. Abbreviations: as in Figure 4; LPL, lipoprotein
lipase.
doi:10.1371/journal.pone.0063374.g007
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lesions might perform an adaptive function by reduction in
modified LDL concentrations in extracellular space of intima. This
reduction will result in decrease of availability of LXR and PPAR
ligands for resident cells and, consequently, in diminishing of
transcriptional activities of these nuclear receptors (which include
induction of SREBP expression as well). On the contrary, massive
formation of foam cells (including smooth muscle-derived) in fatty
streaks is accompanied by reactive oxygen species production
which favors LXR and PPAR ligands accumulation and, in the
end, participation of LXR and PPAR in gene regulation. The
drop in abundance of correlations in fibrolipid plaques as
compared to fatty streaks may relate to qualitative changes in
regulation of LXR and PPAR transcriptional activities. Significant
rise in proportion of negative correlations with LXRb and PPARa
mRNAs is a hallmark of this advanced lesion. Several mechanisms
responsible for transrepressor activities of LXR and PPAR
including their phosphorylation and SUMOylation have been
described [22,23]. One can speculate that, in fibrolipid plaques,
simultaneous presence of both forms of LXRb and PPARa,
activating and inhibitory, leads to quenching of a part of
correlations depending on the context of target regulatory
sequences. Notably, a number of of PPARc mRNA positive
correlations found in fatty streaks persist in fibrolipid plaques. On
the other hand, positive correlations of PPARc with EEA1 and
Rab5 mRNAs in intact aorta transform into negative ones in
atheromas.
Correlations between mRNAs can indicate the following: the
influence of one gene (through its protein product) on the
expression of the other; mutual influences; and, finally, depen-
dence of both on shared regulator(s). Regulatory regions of a
multitude of genes involved in lipid turnover and inflammation
have been shown to contain response elements that render
sensitivity to LXR/PPAR/SREBP group of transcription factors.
However, many of controlled factors within lipid turnover and
inflammation groups have a capability in turn, directly or
indirectly, to affect expression of members of LXR/PPAR/
SREBP group. For example, it was shown that CD36 in ligand-
dependent manner can use signaling machinery of Toll-like
receptors [24], which is known to inhibit LXR-dependent
transcription including ATP-binding cassette transporter A1 (ABCA1)
gene [25]. Furthermore, mutual dependence of expression within
LXR/PPAR/SREBP group (reviewed in [7]) potentially can result
in correlations that reflect activity of shared regulator(s). Thus, the
significance of correlations should not be overestimated in terms of
mechanistic interpretation. Nevertheless, shared correlations can
point to similarities in regulatory mechanisms of expression. It is of
particular value for genes whose regulation is still obscure (e.g. C–
C motif-containing chemokine 18 (CCL18) or endosome/
lysosome components).
Atherosclerosis is known to be a gender-dependent disease
(reviewed, e.g., in [26]). The predominance of SREBP1 mRNA in
female aortas and PPARc mRNA in male aortas found in this
study (Fig. 1A,B) may relate to this issue. Moreover, the correlation
between SREBP2 and estrogen receptor a (ERa) mRNAs was
observed among the most conservative correlations (Fig. 4).
Together with gender difference in changes of the contents of
SREBP2 mRNA in fatty streak (Fig. 2B), the data allow speculate
that atheroprotective effects of estrogens may involve induction of
SREBP genes.
The analysis of correlations between the contents of LXR/
PPAR/SREBP mRNAs in intact and injured tissue was intended
for elucidation of a role of systemic factors in regulation of these
mRNAs during the disease progression. Unlike other mRNA
species, PPARc mRNA in any lesion type did not correlate with its
content in intact tissue. It may mean that systemic factors have
only limited if any influence on the expression of PPARc in injured
tissue. The loss of coupling between the contents of LXRa and
SREBP1 mRNAs in advanced lesion and intact tissue may relate
to changes in cell composition though a shift in predominant
regulators cannot be ruled out as well.
The response of macrophages to lipid loading (up-regulation of
LXRb and PPARa mRNAs) only partially coincides with changes
in LXR/PPAR/SREBP mRNAs group in the aortic intima during
atherogenesis. It may mean that the regulatory mechanisms in
macrophages and resident cells in the aorta differ. However,
similarly to fatty streak, lipid loading induces significant rise in the
number of mRNAs correlations in macrophages. It points to
‘‘stressful’’ influence of lipids on both resident cells of the arterial
wall and macrophages, although the ways of this influence can be
cell-specific. For example, correlation between LXRb and SR-BI
mRNAs in lesion of type Va was positive while in macrophages
this correlation had an opposite sign.
In conclusion, transcriptional regulators of lipid metabolism in
the aorta are themselvesthe objects of the regulation at the level of
transcription. As a result of atherosclerosis progression, the
contents of mRNAs for LXRa/b, PPARa/c, and SREBP1
progressively rise. However, the coupling between mRNAs for
LXR/PPAR/SREBP and other mRNA species changes in the
course of atherogenesis in non-linear manner and individually for
each type of mRNA. These findings should be taken into
consideration when targeting LXR/PPAR/SREBP therapy is
contemplated.
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